Related Experiment Video

Updated: Oct 14, 2025

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

565

Pulmonary mucormycosis-a case series

Santhosh Regini Benjamin1, Deepak Narayanan1, Sujith Thomas Chandy2

  • 1The Department of Cardiothoracic Surgery, The Christian Medical College, Vellore, Tamil Nadu 632004 India.

Indian Journal of Thoracic and Cardiovascular Surgery
|November 8, 2021
PubMed

Insights

Pulmonary mucormycosis (PM) is a rare fungal infection. This study analyzes surgical management of PM in India before the COVID-19 pandemic, offering insights into this under-researched condition.

Area of Science:

  • Medicine
  • Infectious Diseases
  • Pulmonology

Background:

  • Pulmonary mucormycosis (PM) is a rare, invasive fungal infection.
  • Limited literature exists on the surgical management of PM in India.
  • Recent increases in mucormycosis cases linked to COVID-19 highlight the need for more data.

Purpose of the Study:

  • To analyze surgical experience with pulmonary mucormycosis in India.
  • To provide insights into the disease management prior to the COVID-19 pandemic.

Main Methods:

  • Retrospective analysis of a departmental database.
  • Inclusion of 10 adult patients with isolated PM who underwent surgery.
  • Data collected from 2009 to 2020.

Main Results:

  • Surgical management of 10 adult patients with isolated pulmonary mucormycosis was reviewed.
  • Data spans a decade (2009-2020) from a tertiary care center.
  • Analysis focuses on pre-pandemic surgical interventions.

Conclusions:

  • Surgical intervention is a key aspect of managing pulmonary mucormycosis.
  • Understanding pre-pandemic surgical outcomes is crucial for current clinical practice.
  • Further research is needed to address the sparse literature on PM surgical management in India.
Keywords:
CorticosteroidDiabetes MellitusLobectomyMucormycosisPulmonarySurgery

More Related Videos

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis09:52

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

10.7K
A Mouse Model of Pulmonary Fibrosis Induced by Nasal Bleomycin Nebulization02:46

A Mouse Model of Pulmonary Fibrosis Induced by Nasal Bleomycin Nebulization

Published on: January 20, 2023

4.1K

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
632
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
516
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
406
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
265
Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
273
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
227